Life ScienceCompany
BioSpecifics Technologies Ownership
Who owns BioSpecifics Technologies?
BioSpecifics Technologies is owned by Endo International. It was acquired on October 19, 2020.
BioSpecifics Technologies Business Overview
Where is BioSpecifics Technologies headquartered?
BioSpecifics Technologies is headquartered in Wilmington, Delaware.
What sector is BioSpecifics Technologies in?
BioSpecifics Technologies is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.